AI Science Tracker
EN

Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients

Lishui People's Hospital · 31 Jan 2024 · medicine

Discovery

Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients

Source check: Source checked. Not independent scientific confirmation.

Finding: Original full text, Methods/Results: ML models used equivalent uniform dose features for grade≥2 radiation pneumonitis after VMAT in 77 lung-cancer patients; decision-tree AUC .98 with 70/30 split and five-fold CV. Small single-center internal evaluation. Methods/Results specify cohort, reference/outcome, split or experimental comparator and limitations.

Technology: Equivalent-uniform-dose-feature machine-learning models

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Uses equivalent uniform dose features to predict grade 2 or higher radiation pneumonitis after VMAT in 77 lung-cancer patients.
Test and result
Original full text, Methods/Results: ML models used equivalent uniform dose features for grade≥2 radiation pneumonitis after VMAT in 77 lung-cancer patients; decision-tree AUC .98 with 70/30 split and five-fold CV. Small single-center internal evaluation.
Limitation / still unknown
Methods/Results specify cohort, reference/outcome, split or experimental comparator and limitations. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1343170/full · https://europepmc.org/article/MED/38357195

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.